Education
About Us
Working with TipRanks
Follow Us
Starpharma Holdings Limited (AU:SPL)
:SPL
RESEARCH TOOLSreports
SPL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.13
Previous CloseN/A
Volume337.59K
Average Volume (3M)289.10K
Market Cap
AU$40.99M
Enterprise ValueAU$27.98M
Total Cash (Recent Filing)AU$20.28M
Total Debt (Recent Filing)AU$2.48M
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Aug 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding418,224,800
10 Day Avg. Volume319,802
30 Day Avg. Volume289,103
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Starpharma Holdings Limited News
SPL FAQ
What was Starpharma Holdings Limited’s price range in the past 12 months?
Starpharma Holdings Limited lowest share price was AU$0.08 and its highest was AU$0.13 in the past 12 months.
What is Starpharma Holdings Limited’s market cap?
Starpharma Holdings Limited’s market cap is AU$40.99M.
When is Starpharma Holdings Limited’s upcoming earnings report date?
Starpharma Holdings Limited’s upcoming earnings report date is Aug 20, 2025 which is in 12 days.
How were Starpharma Holdings Limited’s earnings last quarter?
Starpharma Holdings Limited released its earnings results on Feb 25, 2025. The company reported -AU$0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.013.
Is Starpharma Holdings Limited overvalued?
According to Wall Street analysts Starpharma Holdings Limited’s price is currently Overvalued.
Does Starpharma Holdings Limited pay dividends?
Starpharma Holdings Limited does not currently pay dividends.
What is Starpharma Holdings Limited’s EPS estimate?
Starpharma Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Starpharma Holdings Limited have?
Starpharma Holdings Limited has 418,224,800 shares outstanding.
What happened to Starpharma Holdings Limited’s price movement after its last earnings report?
Starpharma Holdings Limited reported an EPS of -AU$0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.348%.
Which hedge fund is a major shareholder of Starpharma Holdings Limited?
Currently, no hedge funds are holding shares in AU:SPL
Starpharma Holdings Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Neutral
AU:SPL Sentiment 50%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.22%
12-Months-Change
Fundamentals
Return on Equity
-43.63%
Trailing 12-Months
Asset Growth
-38.83%
Trailing 12-Months
Company Description
Starpharma Holdings Limited
Starpharma Holdings Limited (SPL) is an Australian-based biotechnology company specializing in the development of dendrimer products for pharmaceutical, life sciences, and other applications. The company's core products include its proprietary VivaGel® portfolio, which is used for antiviral and antimicrobial purposes, and DEP® drug delivery platform, which enhances the delivery and efficacy of pharmaceuticals. Starpharma operates primarily in the healthcare and pharmaceutical sectors, leveraging its proprietary intellectual property in dendrimer technology.
Technical Analysis
Prescient Therapeutics Limited
―
Cynata Therapeutics Limited
―
Island Pharmaceuticals Ltd
―
Noxopharm Ltd.
―
Avecho Biotechnology Limited
―
Ownership Overview
1.00% Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---